?:authorAffiliation
|
-
[\'Biogazelle, Zwijnaarde, Belgium; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.\', \'UCB, Braine-l\'Alleud, Belgium.\', \'Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium.\', \'Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.\', \'Federal Agency for Medicines and Health Products, Brussels, Belgium.\', \'Biogazelle, Zwijnaarde, Belgium.\', \'Service of Viral Diseases, Operational Directorate Infectious Diseases in Humans, Sciensano, Brussels, Belgium.\', \'Center for Infectious Diseases, Queen Astrid Military Hospital, Brussels, Belgium; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.\', \'Center for Infectious Diseases, Queen Astrid Military Hospital, Brussels, Belgium.\', \'Federal Agency for Medicines and Health Products, Brussels, Belgium; Unit of Pharmacology, Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium; Department of Biomedical Sciences, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.\', \'Laboratory of Clinical Bacteriology and Mycology, KU Leuven, Leuven, Belgium.\', \'Biogazelle, Zwijnaarde, Belgium; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. Electronic address: jo.vandesompele@biogazelle.com.\']
|